Adaptive Biotechnologies Corp (ADPT)
2.61
+0.01
(+0.38%)
USD |
NASDAQ |
Apr 25, 16:00
2.61
0.00 (0.00%)
After-Hours: 20:00
Adaptive Biotechnologies Shareholders Equity (Quarterly): 308.40M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 308.40M |
| September 30, 2023 | 361.73M |
| June 30, 2023 | 396.04M |
| March 31, 2023 | 424.02M |
| December 31, 2022 | 464.16M |
| September 30, 2022 | 487.84M |
| June 30, 2022 | 518.30M |
| March 31, 2022 | 553.20M |
| December 31, 2021 | 603.99M |
| September 30, 2021 | 651.51M |
| June 30, 2021 | 693.18M |
| Date | Value |
|---|---|
| March 31, 2021 | 725.59M |
| December 31, 2020 | 743.27M |
| September 30, 2020 | 775.05M |
| June 30, 2020 | 529.94M |
| March 31, 2020 | 551.56M |
| December 31, 2019 | 571.04M |
| September 30, 2019 | 585.92M |
| June 30, 2019 | -284.37M |
| March 31, 2019 | 288.10M |
| December 31, 2018 | -258.11M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-284.37M
Minimum
Jun 2019
775.05M
Maximum
Sep 2020
508.44M
Average
551.56M
Median
Mar 2020
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 39.70M |
| Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 661.13M |
| Total Liabilities (Quarterly) | 352.86M |
| Current Ratio | 4.660 |